Gilbert SC - Search Results

1

Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.

Bejon P, Mwacharo J, Kai OK, Todryk S, Keating S, Lang T, Gilbert SC, Peshu N, Marsh K, Hill AV. Bejon P, et al. Among authors: gilbert sc. Vaccine. 2006 May 29;24(22):4709-15. doi: 10.1016/j.vaccine.2006.03.029. Epub 2006 Mar 31. Vaccine. 2006. PMID: 16621181 Clinical Trial.

2

Genetic analysis of host-parasite coevolution in human malaria.

Hill AV, Jepson A, Plebanski M, Gilbert SC. Hill AV, et al. Among authors: gilbert sc. Philos Trans R Soc Lond B Biol Sci. 1997 Sep 29;352(1359):1317-25. doi: 10.1098/rstb.1997.0116. Philos Trans R Soc Lond B Biol Sci. 1997. PMID: 9355123 Free PMC article. Review.

3

A protein particle vaccine containing multiple malaria epitopes.

Gilbert SC, Plebanski M, Harris SJ, Allsopp CE, Thomas R, Layton GT, Hill AV. Gilbert SC, et al. Nat Biotechnol. 1997 Nov;15(12):1280-4. doi: 10.1038/nbt1197-1280. Nat Biotechnol. 1997. PMID: 9359112

4

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.

Hanke T, Blanchard TJ, Schneider J, Ogg GS, Tan R, Becker M, Gilbert SC, Hill AV, Smith GL, McMichael A. Hanke T, et al. Among authors: gilbert sc. J Gen Virol. 1998 Jan;79 ( Pt 1):83-90. doi: 10.1099/0022-1317-79-1-83. J Gen Virol. 1998. PMID: 9460927

5

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime.

Hanke T, Blanchard TJ, Schneider J, Hannan CM, Becker M, Gilbert SC, Hill AV, Smith GL, McMichael A. Hanke T, et al. Among authors: gilbert sc. Vaccine. 1998 Mar;16(5):439-45. doi: 10.1016/s0264-410x(97)00226-0. Vaccine. 1998. PMID: 9491498

6

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.

Schneider J, Gilbert SC, Blanchard TJ, Hanke T, Robson KJ, Hannan CM, Becker M, Sinden R, Smith GL, Hill AV. Schneider J, et al. Among authors: gilbert sc. Nat Med. 1998 Apr;4(4):397-402. doi: 10.1038/nm0498-397. Nat Med. 1998. PMID: 9546783

7

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

Hanke T, Schneider J, Gilbert SC, Hill AV, McMichael A. Hanke T, et al. Among authors: gilbert sc. Vaccine. 1998 Feb;16(4):426-35. doi: 10.1016/s0264-410x(97)00296-x. Vaccine. 1998. PMID: 9607066

8

Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; comparisons and combinations.

Gilbert SC, Schneider J, Plebanski M, Hannan CM, Blanchard TJ, Smith GL, Hill AV. Gilbert SC, et al. Biol Chem. 1999 Mar;380(3):299-303. doi: 10.1515/BC.1999.041. Biol Chem. 1999. PMID: 10223332

9

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models.

Dégano P, Schneider J, Hannan CM, Gilbert SC, Hill AV. Dégano P, et al. Among authors: gilbert sc. Vaccine. 1999 Nov 12;18(7-8):623-32. doi: 10.1016/s0264-410x(99)00278-9. Vaccine. 1999. PMID: 10547421

10

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.

Schneider J, Gilbert SC, Hannan CM, Dégano P, Prieur E, Sheu EG, Plebanski M, Hill AV. Schneider J, et al. Among authors: gilbert sc. Immunol Rev. 1999 Aug;170:29-38. doi: 10.1111/j.1600-065x.1999.tb01326.x. Immunol Rev. 1999. PMID: 10566139 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page